Studies of IL28B genotype and response to peginterferon in chronic hepatitis B should be stratified by HBV genotype

Hepatology

Volumn 57, Issue 3, 2013, Pages 1283-1284

  Lampertico, Pietro ^a   Galmozzi, Enrico ^a   Colombo, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 28B; PEGINTERFERON; RIBAVIRIN; ALPHA INTERFERON; IL28B PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2B; RECOMBINANT PROTEIN;

CHRONIC HEPATITIS; DRUG RESPONSE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; ITALY; LETTER; NONHUMAN; PHARMACOGENETICS; PREDICTION AND FORECASTING; PRIORITY JOURNAL; STRATIFIED SAMPLE; FEMALE; GENETICS; HEPATITIS C VIRUS; MALE; NOTE;

FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; INTERLEUKINS; MALE; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS;

EID: 84874491566     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25882     Document Type: Letter

References (3)

1. Lampertico P, Vigano M, Cheroni C, Facchetti F, Invernizzi F, Valveri V, et al. IL28B polymorphisms predict interferon-related HBsAg seroclearance in genotype D HBeAg-negative patients with chronic hepatitis B. HEPATOLOGY 2013;57:xx-xx.
2. Sonneveld MJ, Wong VW, Woltman AM, Wong GL, Cakaloglu Y, Zeuzem S, et al. Polymorphisms near IL28B and serological response to peginterferon in HBeAg-positive patients with chronic hepatitis B. Gastroenterology 2012; 142: 513-520.
3. Fischer J, Bohm S, Scholz M, Muller T, Witt H, George J, et al. Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 Infection. HEPATOLOGY 2012 [Epub ahead of print].